Paion AG initiates Phase II trial of remimazolam for Anaesthesia
Paion AG will conduct a Phase II trial with short acting anaesthic/sedative remimazolam in general anaesthesia in cardiac surgery in the second half of 2013.Ono Pharma have completed a successful Phase II trial for remimazolam in Japan in general aneasthesia and are conducting a Phase II/III trial.
The clinical studies performed with remimazolam comprise four Phase I and three Phase II studies with single or multiple dose without an intervention or during endoscopy of the upper gastrointestinal tract or the colon or in anaesthesia.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.
1 mins